Skip to main content
Clinical Trials/NCT00658450
NCT00658450
Completed
N/A

A Randomised Trial to Investigate the Effect of a Rehabilitation Program for Cognitive Deficits in Ugandan Children After Cerebral Malaria.

Makerere University1 site in 1 country123 target enrollmentFebruary 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Malaria, Cerebral
Sponsor
Makerere University
Enrollment
123
Locations
1
Primary Endpoint
Improvement in attention scores
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to determine whether computerised cognitive rehabilitation training improves cognition in children who have had cerebral malaria.

Detailed Description

Cerebral malaria affects several children in sub-Saharan Africa leaving some survivors with cognitive problems especially in attention and memory. There are currently no tested interventions for such deficits resulting from infectious diseases like malaria or other causes. Providing such interventions will go a long way in helping these children achieve their full potential.

Registry
clinicaltrials.gov
Start Date
February 2008
End Date
October 2010
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Paul Bangirana

Dr Paul Bangirana

Makerere University

Eligibility Criteria

Inclusion Criteria

  • aged five to 15 years, presenting with asexual forms of P. falciparum malaria on a peripheral blood smear, unarousable coma (not able to localize a painful stimulus) and no other cause for coma (normal CSF).

Exclusion Criteria

  • history of or present meningitis, encephalitis, prior CM, sickle cell disease (SCD), HIV infection, epilepsy, multiple seizures, developmental delay and history of hospitalization for malnutrition.
  • Healthy control group Inclusion Criteria:
  • aged five to 15 years with no other illness at present, within two years of the CM child (for CM children aged 5 and 6 years, the HC's age wont go below 5 and for CM children aged 14 and 15, the HC's age wont go above 15 years).
  • Healthy control group Exclusion Criteria:
  • history of or present bacterial meningitis, encephalitis, CM, SCD, HIV infection, history of hospitalization for malnutrition and any chronic illness for which the patient is currently taking medication.

Outcomes

Primary Outcomes

Improvement in attention scores

Time Frame: 6 months

Secondary Outcomes

  • Improvement in memory, reasoning, planning, behaviour and academic achievement(6 months)

Study Sites (1)

Loading locations...

Similar Trials